University of Leicester
Browse

Lessons learnt when accounting for competing events in the external validation of time-to-event prognostic models

Download (729.53 kB)
journal contribution
posted on 2022-08-26, 11:00 authored by Chava L. Ramspek, Lucy Teece, Kym I.E. Snell, Marie Evans, Richard D. Riley, Maarten van Smeden, Nan van Geloven, Merel van Diepen

Background: External validation of prognostic models is necessary to assess the accuracy and generalizability of the model to new patients. If models are validated in a setting in which competing events occur, these competing risks should be accounted for when comparing predicted risks to observed outcomes. 

Methods: We discuss existing measures of calibration and discrimination that incorporate competing events for time-to-event models. These methods are illustrated using a clinical-data example concerning the prediction of kidney failure in a population with advanced chronic kidney disease (CKD), using the guideline-recommended Kidney Failure Risk Equation (KFRE). The KFRE was developed using Cox regression in a diverse population of CKD patients and has been proposed for use in patients with advanced CKD in whom death is a frequent competing event. 

Results: When validating the 5-year KFRE with methods that account for competing events, it becomes apparent that the 5-year KFRE considerably overestimates the real-world risk of kidney failure. The absolute overestimation was 10%age points on average and 29%age points in older high-risk patients. Conclusions: It is crucial that competing events are accounted for during external validation to provide a more reliable assessment the performance of a model in clinical settings in which competing risks occur.

Funding

The work on this study by M.v.D. was supported by a grant from the Dutch Kidney Foundation [grant number 16OKG12]. K.I.E.S. is funded by the National Institute for Health Research School for Primary Care Research (NIHR SPCR Launching Fellowship). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. M.E. was funded by a grant from the Center for Innovative Medicine (CIMED) and ALF Medicin. L.T. is supported by the UK National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM).

History

Citation

International Journal of Epidemiology, 2021, Vol. 51, No. 2

Author affiliation

Department of Health Sciences

Version

  • VoR (Version of Record)

Published in

International Journal of Epidemiology

Volume

51

Issue

2

Pagination

615–625

Publisher

Oxford University Press (OUP)

issn

0300-5771

eissn

1464-3685

Acceptance date

2021-11-24

Copyright date

2021

Available date

2022-08-26

Language

en

Usage metrics

    University of Leicester Publications

    Categories

    No categories selected

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC